Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Blind Phase I Study to Assess the Residual Allergenicity of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL Using Skin Prick Testing

NCT00116285 is registered in ClinicalTrials.gov with Allergy Therapeutics as lead sponsor.

NCT NCT00116285
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00116285 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Blind Phase I Study to Assess the Residual Allergenicity of Tyrosine Adsorbed Ragweed Pollen Allergoid With MPL Using Skin Prick Testing
Lead sponsor
Allergy Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2005
Completion date
June 30, 2005
Enrollment
12
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type i hypersensitivity